nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—OPRD1—epilepsy syndrome	0.187	0.485	CbGaD
Hydromorphone—OPRM1—epilepsy syndrome	0.143	0.371	CbGaD
Hydromorphone—CYP2D6—epilepsy syndrome	0.0554	0.144	CbGaD
Hydromorphone—UGT1A9—Propofol—epilepsy syndrome	0.0524	0.157	CbGbCtD
Hydromorphone—UGT1A9—Valproic Acid—epilepsy syndrome	0.0375	0.112	CbGbCtD
Hydromorphone—PTGS1—Diazepam—epilepsy syndrome	0.0197	0.059	CbGbCtD
Hydromorphone—PTGS1—Valproic Acid—epilepsy syndrome	0.0156	0.0465	CbGbCtD
Hydromorphone—CYP2C9—Trimethadione—epilepsy syndrome	0.0155	0.0464	CbGbCtD
Hydromorphone—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0146	0.0436	CbGbCtD
Hydromorphone—CYP2C9—Carbamazepine—epilepsy syndrome	0.0105	0.0313	CbGbCtD
Hydromorphone—CYP2C9—Primidone—epilepsy syndrome	0.00978	0.0292	CbGbCtD
Hydromorphone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0097	0.029	CbGbCtD
Hydromorphone—CYP2C9—Phenytoin—epilepsy syndrome	0.0094	0.0281	CbGbCtD
Hydromorphone—CYP3A4—Felbamate—epilepsy syndrome	0.00902	0.027	CbGbCtD
Hydromorphone—CYP3A4—Trimethadione—epilepsy syndrome	0.00902	0.027	CbGbCtD
Hydromorphone—CYP2C9—Propofol—epilepsy syndrome	0.00877	0.0262	CbGbCtD
Hydromorphone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00848	0.0253	CbGbCtD
Hydromorphone—CYP2C9—Phenobarbital—epilepsy syndrome	0.00838	0.025	CbGbCtD
Hydromorphone—CYP2D6—Propofol—epilepsy syndrome	0.00802	0.0239	CbGbCtD
Hydromorphone—CYP2C9—Diazepam—epilepsy syndrome	0.00794	0.0237	CbGbCtD
Hydromorphone—CYP3A4—Clonazepam—epilepsy syndrome	0.00767	0.0229	CbGbCtD
Hydromorphone—CYP3A4—Clobazam—epilepsy syndrome	0.00735	0.022	CbGbCtD
Hydromorphone—CYP2C9—Valproic Acid—epilepsy syndrome	0.00626	0.0187	CbGbCtD
Hydromorphone—CYP3A4—Rufinamide—epilepsy syndrome	0.00625	0.0187	CbGbCtD
Hydromorphone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00609	0.0182	CbGbCtD
Hydromorphone—CYP3A4—Primidone—epilepsy syndrome	0.00569	0.017	CbGbCtD
Hydromorphone—CYP3A4—Phenytoin—epilepsy syndrome	0.00547	0.0163	CbGbCtD
Hydromorphone—CYP3A4—Propofol—epilepsy syndrome	0.0051	0.0152	CbGbCtD
Hydromorphone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00487	0.0146	CbGbCtD
Hydromorphone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00487	0.0146	CbGbCtD
Hydromorphone—CYP3A4—Midazolam—epilepsy syndrome	0.0048	0.0144	CbGbCtD
Hydromorphone—CYP3A4—Diazepam—epilepsy syndrome	0.00462	0.0138	CbGbCtD
Hydromorphone—CYP3A4—Zonisamide—epilepsy syndrome	0.00451	0.0135	CbGbCtD
Hydromorphone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00364	0.0109	CbGbCtD
Hydromorphone—CYP3A4—Topiramate—epilepsy syndrome	0.00328	0.00981	CbGbCtD
Hydromorphone—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00229	0.114	CbGeAlD
Hydromorphone—OPRD1—ganglion—epilepsy syndrome	0.00209	0.104	CbGeAlD
Hydromorphone—OPRM1—ganglion—epilepsy syndrome	0.00142	0.0709	CbGeAlD
Hydromorphone—OPRD1—forebrain—epilepsy syndrome	0.000876	0.0436	CbGeAlD
Hydromorphone—OPRK1—forebrain—epilepsy syndrome	0.000839	0.0418	CbGeAlD
Hydromorphone—OPRD1—telencephalon—epilepsy syndrome	0.000805	0.0401	CbGeAlD
Hydromorphone—PTGS1—ganglion—epilepsy syndrome	0.000694	0.0346	CbGeAlD
Hydromorphone—OPRM1—brainstem—epilepsy syndrome	0.000619	0.0308	CbGeAlD
Hydromorphone—OPRM1—forebrain—epilepsy syndrome	0.000597	0.0297	CbGeAlD
Hydromorphone—OPRM1—telencephalon—epilepsy syndrome	0.000549	0.0273	CbGeAlD
Hydromorphone—OPRD1—head—epilepsy syndrome	0.000501	0.025	CbGeAlD
Hydromorphone—OPRK1—head—epilepsy syndrome	0.000481	0.0239	CbGeAlD
Hydromorphone—OPRD1—nervous system—epilepsy syndrome	0.000475	0.0237	CbGeAlD
Hydromorphone—OPRD1—central nervous system—epilepsy syndrome	0.000458	0.0228	CbGeAlD
Hydromorphone—OPRK1—nervous system—epilepsy syndrome	0.000456	0.0227	CbGeAlD
Hydromorphone—OPRK1—central nervous system—epilepsy syndrome	0.000439	0.0218	CbGeAlD
Hydromorphone—CYP2D6—hindbrain—epilepsy syndrome	0.000433	0.0215	CbGeAlD
Hydromorphone—OPRK1—cerebellum—epilepsy syndrome	0.000429	0.0213	CbGeAlD
Hydromorphone—OPRM1—midbrain—epilepsy syndrome	0.000394	0.0196	CbGeAlD
Hydromorphone—OPRM1—spinal cord—epilepsy syndrome	0.000385	0.0192	CbGeAlD
Hydromorphone—OPRD1—brain—epilepsy syndrome	0.000363	0.0181	CbGeAlD
Hydromorphone—OPRK1—brain—epilepsy syndrome	0.000348	0.0173	CbGeAlD
Hydromorphone—OPRM1—head—epilepsy syndrome	0.000342	0.017	CbGeAlD
Hydromorphone—OPRM1—nervous system—epilepsy syndrome	0.000324	0.0161	CbGeAlD
Hydromorphone—OPRM1—central nervous system—epilepsy syndrome	0.000312	0.0155	CbGeAlD
Hydromorphone—PTGS1—forebrain—epilepsy syndrome	0.000291	0.0145	CbGeAlD
Hydromorphone—PTGS1—telencephalon—epilepsy syndrome	0.000268	0.0133	CbGeAlD
Hydromorphone—Heroin—OPRD1—epilepsy syndrome	0.000254	0.0539	CrCbGaD
Hydromorphone—CYP2D6—brainstem—epilepsy syndrome	0.000248	0.0123	CbGeAlD
Hydromorphone—OPRM1—brain—epilepsy syndrome	0.000248	0.0123	CbGeAlD
Hydromorphone—CYP2D6—forebrain—epilepsy syndrome	0.000239	0.0119	CbGeAlD
Hydromorphone—CYP2D6—telencephalon—epilepsy syndrome	0.00022	0.011	CbGeAlD
Hydromorphone—Nalbuphine—OPRD1—epilepsy syndrome	0.000207	0.044	CrCbGaD
Hydromorphone—Levorphanol—OPRD1—epilepsy syndrome	0.0002	0.0423	CrCbGaD
Hydromorphone—Heroin—OPRM1—epilepsy syndrome	0.000195	0.0413	CrCbGaD
Hydromorphone—PTGS1—spinal cord—epilepsy syndrome	0.000188	0.00934	CbGeAlD
Hydromorphone—Methylnaltrexone—OPRM1—epilepsy syndrome	0.000174	0.0368	CrCbGaD
Hydromorphone—Naltrexone—OPRD1—epilepsy syndrome	0.000169	0.0358	CrCbGaD
Hydromorphone—Oxymorphone—OPRD1—epilepsy syndrome	0.000169	0.0358	CrCbGaD
Hydromorphone—PTGS1—head—epilepsy syndrome	0.000167	0.0083	CbGeAlD
Hydromorphone—Nalbuphine—OPRM1—epilepsy syndrome	0.000159	0.0336	CrCbGaD
Hydromorphone—Dextromethorphan—CHRNA2—epilepsy syndrome	0.000158	0.0336	CrCbGaD
Hydromorphone—PTGS1—nervous system—epilepsy syndrome	0.000158	0.00787	CbGeAlD
Hydromorphone—Dextromethorphan—CHRNB2—epilepsy syndrome	0.000155	0.0329	CrCbGaD
Hydromorphone—Levorphanol—OPRM1—epilepsy syndrome	0.000153	0.0324	CrCbGaD
Hydromorphone—PTGS1—central nervous system—epilepsy syndrome	0.000152	0.00758	CbGeAlD
Hydromorphone—Naloxone—SLCO1A2—epilepsy syndrome	0.000148	0.0314	CrCbGaD
Hydromorphone—Hydrocodone—OPRD1—epilepsy syndrome	0.000148	0.0313	CrCbGaD
Hydromorphone—Dihydrocodeine—OPRM1—epilepsy syndrome	0.000148	0.0313	CrCbGaD
Hydromorphone—CYP2D6—head—epilepsy syndrome	0.000137	0.00682	CbGeAlD
Hydromorphone—Oxycodone—OPRD1—epilepsy syndrome	0.000135	0.0286	CrCbGaD
Hydromorphone—CYP3A4—nervous system—epilepsy syndrome	0.000132	0.00657	CbGeAlD
Hydromorphone—CYP2D6—nervous system—epilepsy syndrome	0.00013	0.00647	CbGeAlD
Hydromorphone—Naltrexone—OPRM1—epilepsy syndrome	0.000129	0.0274	CrCbGaD
Hydromorphone—Oxymorphone—OPRM1—epilepsy syndrome	0.000129	0.0274	CrCbGaD
Hydromorphone—Codeine—OPRD1—epilepsy syndrome	0.000129	0.0273	CrCbGaD
Hydromorphone—CYP3A4—central nervous system—epilepsy syndrome	0.000127	0.00633	CbGeAlD
Hydromorphone—CYP2D6—central nervous system—epilepsy syndrome	0.000125	0.00623	CbGeAlD
Hydromorphone—Ethylmorphine—OPRM1—epilepsy syndrome	0.000124	0.0262	CrCbGaD
Hydromorphone—Naloxone—OPRD1—epilepsy syndrome	0.000123	0.0261	CrCbGaD
Hydromorphone—CYP2D6—cerebellum—epilepsy syndrome	0.000122	0.00609	CbGeAlD
Hydromorphone—PTGS1—brain—epilepsy syndrome	0.000121	0.00602	CbGeAlD
Hydromorphone—Hydrocodone—OPRM1—epilepsy syndrome	0.000113	0.024	CrCbGaD
Hydromorphone—Morphine—OPRD1—epilepsy syndrome	0.000104	0.0221	CrCbGaD
Hydromorphone—Oxycodone—OPRM1—epilepsy syndrome	0.000103	0.0219	CrCbGaD
Hydromorphone—CYP2D6—brain—epilepsy syndrome	9.93e-05	0.00494	CbGeAlD
Hydromorphone—Codeine—OPRM1—epilepsy syndrome	9.85e-05	0.0209	CrCbGaD
Hydromorphone—Naloxone—OPRM1—epilepsy syndrome	9.44e-05	0.02	CrCbGaD
Hydromorphone—Dextromethorphan—CHRNA7—epilepsy syndrome	9.1e-05	0.0193	CrCbGaD
Hydromorphone—Dextromethorphan—OPRD1—epilepsy syndrome	8.75e-05	0.0185	CrCbGaD
Hydromorphone—Morphine—OPRM1—epilepsy syndrome	7.97e-05	0.0169	CrCbGaD
Hydromorphone—Dextromethorphan—CHRNA4—epilepsy syndrome	7.28e-05	0.0154	CrCbGaD
Hydromorphone—Methylnaltrexone—CYP2D6—epilepsy syndrome	6.72e-05	0.0142	CrCbGaD
Hydromorphone—Dextromethorphan—OPRM1—epilepsy syndrome	6.69e-05	0.0142	CrCbGaD
Hydromorphone—Dihydrocodeine—CYP2D6—epilepsy syndrome	5.71e-05	0.0121	CrCbGaD
Hydromorphone—Oxymorphone—CYP2D6—epilepsy syndrome	5.01e-05	0.0106	CrCbGaD
Hydromorphone—Ethylmorphine—CYP2D6—epilepsy syndrome	4.79e-05	0.0101	CrCbGaD
Hydromorphone—Hydrocodone—CYP2D6—epilepsy syndrome	4.38e-05	0.00928	CrCbGaD
Hydromorphone—Oxycodone—CYP2D6—epilepsy syndrome	4e-05	0.00847	CrCbGaD
Hydromorphone—Codeine—CYP2D6—epilepsy syndrome	3.81e-05	0.00808	CrCbGaD
Hydromorphone—Dextromethorphan—SLC6A4—epilepsy syndrome	3.69e-05	0.00781	CrCbGaD
Hydromorphone—Naltrexone—ABCB1—epilepsy syndrome	3.58e-05	0.00758	CrCbGaD
Hydromorphone—Dextromethorphan—CYP2C19—epilepsy syndrome	3.5e-05	0.0074	CrCbGaD
Hydromorphone—Morphine—CYP2D6—epilepsy syndrome	3.09e-05	0.00654	CrCbGaD
Hydromorphone—Naloxone—ALB—epilepsy syndrome	2.74e-05	0.00579	CrCbGaD
Hydromorphone—Naloxone—ABCB1—epilepsy syndrome	2.61e-05	0.00553	CrCbGaD
Hydromorphone—Dextromethorphan—CYP2D6—epilepsy syndrome	2.59e-05	0.00549	CrCbGaD
Hydromorphone—Chest pain—Pregabalin—epilepsy syndrome	2.25e-05	0.000118	CcSEcCtD
Hydromorphone—Myalgia—Pregabalin—epilepsy syndrome	2.25e-05	0.000118	CcSEcCtD
Hydromorphone—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.25e-05	0.000118	CcSEcCtD
Hydromorphone—Dizziness—Zonisamide—epilepsy syndrome	2.25e-05	0.000118	CcSEcCtD
Hydromorphone—Headache—Diazepam—epilepsy syndrome	2.25e-05	0.000118	CcSEcCtD
Hydromorphone—Anxiety—Pregabalin—epilepsy syndrome	2.25e-05	0.000118	CcSEcCtD
Hydromorphone—Diarrhoea—Clonazepam—epilepsy syndrome	2.24e-05	0.000118	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.24e-05	0.000117	CcSEcCtD
Hydromorphone—Hypotension—Valproic Acid—epilepsy syndrome	2.23e-05	0.000117	CcSEcCtD
Hydromorphone—Asthenia—Carbamazepine—epilepsy syndrome	2.23e-05	0.000117	CcSEcCtD
Hydromorphone—Agitation—Gabapentin—epilepsy syndrome	2.23e-05	0.000117	CcSEcCtD
Hydromorphone—Diarrhoea—Phenytoin—epilepsy syndrome	2.23e-05	0.000117	CcSEcCtD
Hydromorphone—Discomfort—Pregabalin—epilepsy syndrome	2.23e-05	0.000117	CcSEcCtD
Hydromorphone—Nausea—Fosphenytoin—epilepsy syndrome	2.22e-05	0.000116	CcSEcCtD
Hydromorphone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.22e-05	0.000116	CcSEcCtD
Hydromorphone—Angioedema—Gabapentin—epilepsy syndrome	2.22e-05	0.000116	CcSEcCtD
Hydromorphone—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.22e-05	0.000116	CcSEcCtD
Hydromorphone—Vomiting—Felbamate—epilepsy syndrome	2.21e-05	0.000116	CcSEcCtD
Hydromorphone—Dry mouth—Pregabalin—epilepsy syndrome	2.2e-05	0.000115	CcSEcCtD
Hydromorphone—Morphine—ABCB1—epilepsy syndrome	2.2e-05	0.00467	CrCbGaD
Hydromorphone—Pruritus—Carbamazepine—epilepsy syndrome	2.2e-05	0.000115	CcSEcCtD
Hydromorphone—Rash—Felbamate—epilepsy syndrome	2.19e-05	0.000115	CcSEcCtD
Hydromorphone—Eye disorder—Topiramate—epilepsy syndrome	2.19e-05	0.000115	CcSEcCtD
Hydromorphone—Dermatitis—Felbamate—epilepsy syndrome	2.19e-05	0.000115	CcSEcCtD
Hydromorphone—Malaise—Gabapentin—epilepsy syndrome	2.19e-05	0.000115	CcSEcCtD
Hydromorphone—Tinnitus—Topiramate—epilepsy syndrome	2.19e-05	0.000114	CcSEcCtD
Hydromorphone—Vertigo—Gabapentin—epilepsy syndrome	2.18e-05	0.000114	CcSEcCtD
Hydromorphone—Headache—Felbamate—epilepsy syndrome	2.18e-05	0.000114	CcSEcCtD
Hydromorphone—Confusional state—Pregabalin—epilepsy syndrome	2.18e-05	0.000114	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.18e-05	0.000114	CcSEcCtD
Hydromorphone—Flushing—Topiramate—epilepsy syndrome	2.18e-05	0.000114	CcSEcCtD
Hydromorphone—Cardiac disorder—Topiramate—epilepsy syndrome	2.18e-05	0.000114	CcSEcCtD
Hydromorphone—Syncope—Gabapentin—epilepsy syndrome	2.18e-05	0.000114	CcSEcCtD
Hydromorphone—Leukopenia—Gabapentin—epilepsy syndrome	2.17e-05	0.000114	CcSEcCtD
Hydromorphone—Dizziness—Clonazepam—epilepsy syndrome	2.17e-05	0.000114	CcSEcCtD
Hydromorphone—Nausea—Vigabatrin—epilepsy syndrome	2.17e-05	0.000114	CcSEcCtD
Hydromorphone—Vomiting—Zonisamide—epilepsy syndrome	2.16e-05	0.000113	CcSEcCtD
Hydromorphone—Insomnia—Valproic Acid—epilepsy syndrome	2.16e-05	0.000113	CcSEcCtD
Hydromorphone—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.16e-05	0.000113	CcSEcCtD
Hydromorphone—Asthenia—Lamotrigine—epilepsy syndrome	2.16e-05	0.000113	CcSEcCtD
Hydromorphone—Dizziness—Phenytoin—epilepsy syndrome	2.16e-05	0.000113	CcSEcCtD
Hydromorphone—Rash—Zonisamide—epilepsy syndrome	2.15e-05	0.000112	CcSEcCtD
Hydromorphone—Infection—Pregabalin—epilepsy syndrome	2.15e-05	0.000112	CcSEcCtD
Hydromorphone—Paraesthesia—Valproic Acid—epilepsy syndrome	2.15e-05	0.000112	CcSEcCtD
Hydromorphone—Palpitations—Gabapentin—epilepsy syndrome	2.14e-05	0.000112	CcSEcCtD
Hydromorphone—Dermatitis—Zonisamide—epilepsy syndrome	2.14e-05	0.000112	CcSEcCtD
Hydromorphone—Dizziness—Oxcarbazepine—epilepsy syndrome	2.14e-05	0.000112	CcSEcCtD
Hydromorphone—Nausea—Diazepam—epilepsy syndrome	2.13e-05	0.000112	CcSEcCtD
Hydromorphone—Loss of consciousness—Gabapentin—epilepsy syndrome	2.13e-05	0.000112	CcSEcCtD
Hydromorphone—Headache—Zonisamide—epilepsy syndrome	2.13e-05	0.000112	CcSEcCtD
Hydromorphone—Dyspnoea—Valproic Acid—epilepsy syndrome	2.13e-05	0.000112	CcSEcCtD
Hydromorphone—Diarrhoea—Carbamazepine—epilepsy syndrome	2.13e-05	0.000111	CcSEcCtD
Hydromorphone—Angiopathy—Topiramate—epilepsy syndrome	2.13e-05	0.000111	CcSEcCtD
Hydromorphone—Pruritus—Lamotrigine—epilepsy syndrome	2.13e-05	0.000111	CcSEcCtD
Hydromorphone—Shock—Pregabalin—epilepsy syndrome	2.13e-05	0.000111	CcSEcCtD
Hydromorphone—Somnolence—Valproic Acid—epilepsy syndrome	2.12e-05	0.000111	CcSEcCtD
Hydromorphone—Immune system disorder—Topiramate—epilepsy syndrome	2.12e-05	0.000111	CcSEcCtD
Hydromorphone—Nervous system disorder—Pregabalin—epilepsy syndrome	2.12e-05	0.000111	CcSEcCtD
Hydromorphone—Cough—Gabapentin—epilepsy syndrome	2.12e-05	0.000111	CcSEcCtD
Hydromorphone—Mediastinal disorder—Topiramate—epilepsy syndrome	2.11e-05	0.000111	CcSEcCtD
Hydromorphone—Tachycardia—Pregabalin—epilepsy syndrome	2.11e-05	0.00011	CcSEcCtD
Hydromorphone—Chills—Topiramate—epilepsy syndrome	2.1e-05	0.00011	CcSEcCtD
Hydromorphone—Dyspepsia—Valproic Acid—epilepsy syndrome	2.1e-05	0.00011	CcSEcCtD
Hydromorphone—Convulsion—Gabapentin—epilepsy syndrome	2.1e-05	0.00011	CcSEcCtD
Hydromorphone—Skin disorder—Pregabalin—epilepsy syndrome	2.1e-05	0.00011	CcSEcCtD
Hydromorphone—Hypertension—Gabapentin—epilepsy syndrome	2.1e-05	0.00011	CcSEcCtD
Hydromorphone—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.09e-05	0.000109	CcSEcCtD
Hydromorphone—Vomiting—Clonazepam—epilepsy syndrome	2.09e-05	0.000109	CcSEcCtD
Hydromorphone—Decreased appetite—Valproic Acid—epilepsy syndrome	2.08e-05	0.000109	CcSEcCtD
Hydromorphone—Vomiting—Phenytoin—epilepsy syndrome	2.07e-05	0.000108	CcSEcCtD
Hydromorphone—Rash—Clonazepam—epilepsy syndrome	2.07e-05	0.000108	CcSEcCtD
Hydromorphone—Dermatitis—Clonazepam—epilepsy syndrome	2.07e-05	0.000108	CcSEcCtD
Hydromorphone—Chest pain—Gabapentin—epilepsy syndrome	2.07e-05	0.000108	CcSEcCtD
Hydromorphone—Myalgia—Gabapentin—epilepsy syndrome	2.07e-05	0.000108	CcSEcCtD
Hydromorphone—Arthralgia—Gabapentin—epilepsy syndrome	2.07e-05	0.000108	CcSEcCtD
Hydromorphone—Nausea—Felbamate—epilepsy syndrome	2.07e-05	0.000108	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.06e-05	0.000108	CcSEcCtD
Hydromorphone—Vomiting—Oxcarbazepine—epilepsy syndrome	2.06e-05	0.000108	CcSEcCtD
Hydromorphone—Fatigue—Valproic Acid—epilepsy syndrome	2.06e-05	0.000108	CcSEcCtD
Hydromorphone—Anxiety—Gabapentin—epilepsy syndrome	2.06e-05	0.000108	CcSEcCtD
Hydromorphone—Anorexia—Pregabalin—epilepsy syndrome	2.06e-05	0.000108	CcSEcCtD
Hydromorphone—Dizziness—Carbamazepine—epilepsy syndrome	2.06e-05	0.000108	CcSEcCtD
Hydromorphone—Diarrhoea—Lamotrigine—epilepsy syndrome	2.06e-05	0.000108	CcSEcCtD
Hydromorphone—Headache—Clonazepam—epilepsy syndrome	2.06e-05	0.000108	CcSEcCtD
Hydromorphone—Rash—Phenytoin—epilepsy syndrome	2.05e-05	0.000108	CcSEcCtD
Hydromorphone—Mental disorder—Topiramate—epilepsy syndrome	2.05e-05	0.000108	CcSEcCtD
Hydromorphone—Dermatitis—Phenytoin—epilepsy syndrome	2.05e-05	0.000107	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.05e-05	0.000107	CcSEcCtD
Hydromorphone—Rash—Oxcarbazepine—epilepsy syndrome	2.04e-05	0.000107	CcSEcCtD
Hydromorphone—Pain—Valproic Acid—epilepsy syndrome	2.04e-05	0.000107	CcSEcCtD
Hydromorphone—Constipation—Valproic Acid—epilepsy syndrome	2.04e-05	0.000107	CcSEcCtD
Hydromorphone—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.04e-05	0.000107	CcSEcCtD
Hydromorphone—Headache—Phenytoin—epilepsy syndrome	2.04e-05	0.000107	CcSEcCtD
Hydromorphone—Erythema—Topiramate—epilepsy syndrome	2.04e-05	0.000107	CcSEcCtD
Hydromorphone—Malnutrition—Topiramate—epilepsy syndrome	2.04e-05	0.000107	CcSEcCtD
Hydromorphone—Discomfort—Gabapentin—epilepsy syndrome	2.04e-05	0.000107	CcSEcCtD
Hydromorphone—Headache—Oxcarbazepine—epilepsy syndrome	2.03e-05	0.000106	CcSEcCtD
Hydromorphone—Nausea—Zonisamide—epilepsy syndrome	2.02e-05	0.000106	CcSEcCtD
Hydromorphone—Dry mouth—Gabapentin—epilepsy syndrome	2.02e-05	0.000106	CcSEcCtD
Hydromorphone—Hypotension—Pregabalin—epilepsy syndrome	2.02e-05	0.000106	CcSEcCtD
Hydromorphone—Flatulence—Topiramate—epilepsy syndrome	2.01e-05	0.000105	CcSEcCtD
Hydromorphone—Tension—Topiramate—epilepsy syndrome	2e-05	0.000105	CcSEcCtD
Hydromorphone—Dysgeusia—Topiramate—epilepsy syndrome	2e-05	0.000105	CcSEcCtD
Hydromorphone—Confusional state—Gabapentin—epilepsy syndrome	2e-05	0.000105	CcSEcCtD
Hydromorphone—Dizziness—Lamotrigine—epilepsy syndrome	1.99e-05	0.000104	CcSEcCtD
Hydromorphone—Nervousness—Topiramate—epilepsy syndrome	1.98e-05	0.000104	CcSEcCtD
Hydromorphone—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.98e-05	0.000104	CcSEcCtD
Hydromorphone—Vomiting—Carbamazepine—epilepsy syndrome	1.98e-05	0.000104	CcSEcCtD
Hydromorphone—Back pain—Topiramate—epilepsy syndrome	1.97e-05	0.000103	CcSEcCtD
Hydromorphone—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.97e-05	0.000103	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.97e-05	0.000103	CcSEcCtD
Hydromorphone—Infection—Gabapentin—epilepsy syndrome	1.97e-05	0.000103	CcSEcCtD
Hydromorphone—Muscle spasms—Topiramate—epilepsy syndrome	1.96e-05	0.000103	CcSEcCtD
Hydromorphone—Rash—Carbamazepine—epilepsy syndrome	1.96e-05	0.000103	CcSEcCtD
Hydromorphone—Dermatitis—Carbamazepine—epilepsy syndrome	1.96e-05	0.000103	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.95e-05	0.000102	CcSEcCtD
Hydromorphone—Insomnia—Pregabalin—epilepsy syndrome	1.95e-05	0.000102	CcSEcCtD
Hydromorphone—Nausea—Clonazepam—epilepsy syndrome	1.95e-05	0.000102	CcSEcCtD
Hydromorphone—Headache—Carbamazepine—epilepsy syndrome	1.95e-05	0.000102	CcSEcCtD
Hydromorphone—Shock—Gabapentin—epilepsy syndrome	1.95e-05	0.000102	CcSEcCtD
Hydromorphone—Nervous system disorder—Gabapentin—epilepsy syndrome	1.94e-05	0.000102	CcSEcCtD
Hydromorphone—Paraesthesia—Pregabalin—epilepsy syndrome	1.94e-05	0.000102	CcSEcCtD
Hydromorphone—Nausea—Phenytoin—epilepsy syndrome	1.94e-05	0.000101	CcSEcCtD
Hydromorphone—Tachycardia—Gabapentin—epilepsy syndrome	1.93e-05	0.000101	CcSEcCtD
Hydromorphone—Dyspnoea—Pregabalin—epilepsy syndrome	1.93e-05	0.000101	CcSEcCtD
Hydromorphone—Nausea—Oxcarbazepine—epilepsy syndrome	1.93e-05	0.000101	CcSEcCtD
Hydromorphone—Vision blurred—Topiramate—epilepsy syndrome	1.92e-05	0.000101	CcSEcCtD
Hydromorphone—Skin disorder—Gabapentin—epilepsy syndrome	1.92e-05	0.000101	CcSEcCtD
Hydromorphone—Somnolence—Pregabalin—epilepsy syndrome	1.92e-05	0.000101	CcSEcCtD
Hydromorphone—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.91e-05	0.0001	CcSEcCtD
Hydromorphone—Tremor—Topiramate—epilepsy syndrome	1.91e-05	0.0001	CcSEcCtD
Hydromorphone—Vomiting—Lamotrigine—epilepsy syndrome	1.91e-05	0.0001	CcSEcCtD
Hydromorphone—Urticaria—Valproic Acid—epilepsy syndrome	1.9e-05	9.94e-05	CcSEcCtD
Hydromorphone—Rash—Lamotrigine—epilepsy syndrome	1.9e-05	9.92e-05	CcSEcCtD
Hydromorphone—Ill-defined disorder—Topiramate—epilepsy syndrome	1.89e-05	9.92e-05	CcSEcCtD
Hydromorphone—Dermatitis—Lamotrigine—epilepsy syndrome	1.89e-05	9.92e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Valproic Acid—epilepsy syndrome	1.89e-05	9.89e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Valproic Acid—epilepsy syndrome	1.89e-05	9.89e-05	CcSEcCtD
Hydromorphone—Anorexia—Gabapentin—epilepsy syndrome	1.89e-05	9.88e-05	CcSEcCtD
Hydromorphone—Headache—Lamotrigine—epilepsy syndrome	1.88e-05	9.86e-05	CcSEcCtD
Hydromorphone—Decreased appetite—Pregabalin—epilepsy syndrome	1.88e-05	9.83e-05	CcSEcCtD
Hydromorphone—Agitation—Topiramate—epilepsy syndrome	1.88e-05	9.82e-05	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.86e-05	9.76e-05	CcSEcCtD
Hydromorphone—Fatigue—Pregabalin—epilepsy syndrome	1.86e-05	9.75e-05	CcSEcCtD
Hydromorphone—Hypotension—Gabapentin—epilepsy syndrome	1.85e-05	9.69e-05	CcSEcCtD
Hydromorphone—Dextromethorphan—ABCB1—epilepsy syndrome	1.85e-05	0.00392	CrCbGaD
Hydromorphone—Nausea—Carbamazepine—epilepsy syndrome	1.85e-05	9.67e-05	CcSEcCtD
Hydromorphone—Pain—Pregabalin—epilepsy syndrome	1.85e-05	9.67e-05	CcSEcCtD
Hydromorphone—Constipation—Pregabalin—epilepsy syndrome	1.85e-05	9.67e-05	CcSEcCtD
Hydromorphone—Malaise—Topiramate—epilepsy syndrome	1.84e-05	9.64e-05	CcSEcCtD
Hydromorphone—Vertigo—Topiramate—epilepsy syndrome	1.83e-05	9.6e-05	CcSEcCtD
Hydromorphone—Syncope—Topiramate—epilepsy syndrome	1.83e-05	9.59e-05	CcSEcCtD
Hydromorphone—Leukopenia—Topiramate—epilepsy syndrome	1.83e-05	9.57e-05	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.8e-05	9.45e-05	CcSEcCtD
Hydromorphone—Palpitations—Topiramate—epilepsy syndrome	1.8e-05	9.45e-05	CcSEcCtD
Hydromorphone—Loss of consciousness—Topiramate—epilepsy syndrome	1.79e-05	9.39e-05	CcSEcCtD
Hydromorphone—Insomnia—Gabapentin—epilepsy syndrome	1.79e-05	9.38e-05	CcSEcCtD
Hydromorphone—Nausea—Lamotrigine—epilepsy syndrome	1.79e-05	9.35e-05	CcSEcCtD
Hydromorphone—Cough—Topiramate—epilepsy syndrome	1.78e-05	9.33e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Pregabalin—epilepsy syndrome	1.78e-05	9.32e-05	CcSEcCtD
Hydromorphone—Paraesthesia—Gabapentin—epilepsy syndrome	1.78e-05	9.31e-05	CcSEcCtD
Hydromorphone—Convulsion—Topiramate—epilepsy syndrome	1.77e-05	9.26e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.77e-05	9.25e-05	CcSEcCtD
Hydromorphone—Dyspnoea—Gabapentin—epilepsy syndrome	1.77e-05	9.24e-05	CcSEcCtD
Hydromorphone—Hypertension—Topiramate—epilepsy syndrome	1.76e-05	9.23e-05	CcSEcCtD
Hydromorphone—Somnolence—Gabapentin—epilepsy syndrome	1.76e-05	9.22e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.76e-05	9.22e-05	CcSEcCtD
Hydromorphone—Dyspepsia—Gabapentin—epilepsy syndrome	1.74e-05	9.13e-05	CcSEcCtD
Hydromorphone—Chest pain—Topiramate—epilepsy syndrome	1.74e-05	9.1e-05	CcSEcCtD
Hydromorphone—Myalgia—Topiramate—epilepsy syndrome	1.74e-05	9.1e-05	CcSEcCtD
Hydromorphone—Arthralgia—Topiramate—epilepsy syndrome	1.74e-05	9.1e-05	CcSEcCtD
Hydromorphone—Anxiety—Topiramate—epilepsy syndrome	1.73e-05	9.07e-05	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.73e-05	9.04e-05	CcSEcCtD
Hydromorphone—Decreased appetite—Gabapentin—epilepsy syndrome	1.72e-05	9.01e-05	CcSEcCtD
Hydromorphone—Discomfort—Topiramate—epilepsy syndrome	1.72e-05	8.99e-05	CcSEcCtD
Hydromorphone—Urticaria—Pregabalin—epilepsy syndrome	1.72e-05	8.98e-05	CcSEcCtD
Hydromorphone—Asthenia—Valproic Acid—epilepsy syndrome	1.71e-05	8.97e-05	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.71e-05	8.95e-05	CcSEcCtD
Hydromorphone—Fatigue—Gabapentin—epilepsy syndrome	1.71e-05	8.94e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Pregabalin—epilepsy syndrome	1.71e-05	8.94e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Pregabalin—epilepsy syndrome	1.71e-05	8.94e-05	CcSEcCtD
Hydromorphone—Dry mouth—Topiramate—epilepsy syndrome	1.7e-05	8.9e-05	CcSEcCtD
Hydromorphone—Pain—Gabapentin—epilepsy syndrome	1.69e-05	8.87e-05	CcSEcCtD
Hydromorphone—Constipation—Gabapentin—epilepsy syndrome	1.69e-05	8.87e-05	CcSEcCtD
Hydromorphone—Pruritus—Valproic Acid—epilepsy syndrome	1.69e-05	8.85e-05	CcSEcCtD
Hydromorphone—Confusional state—Topiramate—epilepsy syndrome	1.68e-05	8.8e-05	CcSEcCtD
Hydromorphone—Infection—Topiramate—epilepsy syndrome	1.66e-05	8.67e-05	CcSEcCtD
Hydromorphone—Shock—Topiramate—epilepsy syndrome	1.64e-05	8.58e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Valproic Acid—epilepsy syndrome	1.63e-05	8.56e-05	CcSEcCtD
Hydromorphone—Nervous system disorder—Topiramate—epilepsy syndrome	1.63e-05	8.56e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Gabapentin—epilepsy syndrome	1.63e-05	8.54e-05	CcSEcCtD
Hydromorphone—Tachycardia—Topiramate—epilepsy syndrome	1.63e-05	8.51e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.62e-05	8.48e-05	CcSEcCtD
Hydromorphone—Skin disorder—Topiramate—epilepsy syndrome	1.62e-05	8.47e-05	CcSEcCtD
Hydromorphone—Hyperhidrosis—Topiramate—epilepsy syndrome	1.61e-05	8.43e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Pregabalin—epilepsy syndrome	1.59e-05	8.33e-05	CcSEcCtD
Hydromorphone—Anorexia—Topiramate—epilepsy syndrome	1.59e-05	8.32e-05	CcSEcCtD
Hydromorphone—Dizziness—Valproic Acid—epilepsy syndrome	1.58e-05	8.27e-05	CcSEcCtD
Hydromorphone—Urticaria—Gabapentin—epilepsy syndrome	1.57e-05	8.24e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Gabapentin—epilepsy syndrome	1.57e-05	8.2e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Gabapentin—epilepsy syndrome	1.57e-05	8.2e-05	CcSEcCtD
Hydromorphone—Hypotension—Topiramate—epilepsy syndrome	1.56e-05	8.15e-05	CcSEcCtD
Hydromorphone—Asthenia—Pregabalin—epilepsy syndrome	1.55e-05	8.11e-05	CcSEcCtD
Hydromorphone—Pruritus—Pregabalin—epilepsy syndrome	1.53e-05	8e-05	CcSEcCtD
Hydromorphone—Vomiting—Valproic Acid—epilepsy syndrome	1.52e-05	7.95e-05	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.52e-05	7.95e-05	CcSEcCtD
Hydromorphone—Insomnia—Topiramate—epilepsy syndrome	1.51e-05	7.89e-05	CcSEcCtD
Hydromorphone—Rash—Valproic Acid—epilepsy syndrome	1.51e-05	7.89e-05	CcSEcCtD
Hydromorphone—Dermatitis—Valproic Acid—epilepsy syndrome	1.51e-05	7.88e-05	CcSEcCtD
Hydromorphone—Headache—Valproic Acid—epilepsy syndrome	1.5e-05	7.84e-05	CcSEcCtD
Hydromorphone—Paraesthesia—Topiramate—epilepsy syndrome	1.5e-05	7.83e-05	CcSEcCtD
Hydromorphone—Dyspnoea—Topiramate—epilepsy syndrome	1.49e-05	7.78e-05	CcSEcCtD
Hydromorphone—Somnolence—Topiramate—epilepsy syndrome	1.48e-05	7.76e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Pregabalin—epilepsy syndrome	1.48e-05	7.74e-05	CcSEcCtD
Hydromorphone—Dyspepsia—Topiramate—epilepsy syndrome	1.47e-05	7.68e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Gabapentin—epilepsy syndrome	1.46e-05	7.64e-05	CcSEcCtD
Hydromorphone—Decreased appetite—Topiramate—epilepsy syndrome	1.45e-05	7.58e-05	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.44e-05	7.53e-05	CcSEcCtD
Hydromorphone—Fatigue—Topiramate—epilepsy syndrome	1.44e-05	7.52e-05	CcSEcCtD
Hydromorphone—Dizziness—Pregabalin—epilepsy syndrome	1.43e-05	7.48e-05	CcSEcCtD
Hydromorphone—Constipation—Topiramate—epilepsy syndrome	1.42e-05	7.46e-05	CcSEcCtD
Hydromorphone—Pain—Topiramate—epilepsy syndrome	1.42e-05	7.46e-05	CcSEcCtD
Hydromorphone—Asthenia—Gabapentin—epilepsy syndrome	1.42e-05	7.44e-05	CcSEcCtD
Hydromorphone—Nausea—Valproic Acid—epilepsy syndrome	1.42e-05	7.43e-05	CcSEcCtD
Hydromorphone—Pruritus—Gabapentin—epilepsy syndrome	1.4e-05	7.34e-05	CcSEcCtD
Hydromorphone—Vomiting—Pregabalin—epilepsy syndrome	1.37e-05	7.19e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Topiramate—epilepsy syndrome	1.37e-05	7.19e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.36e-05	7.13e-05	CcSEcCtD
Hydromorphone—Rash—Pregabalin—epilepsy syndrome	1.36e-05	7.13e-05	CcSEcCtD
Hydromorphone—Dermatitis—Pregabalin—epilepsy syndrome	1.36e-05	7.12e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Gabapentin—epilepsy syndrome	1.36e-05	7.09e-05	CcSEcCtD
Hydromorphone—Headache—Pregabalin—epilepsy syndrome	1.35e-05	7.08e-05	CcSEcCtD
Hydromorphone—Urticaria—Topiramate—epilepsy syndrome	1.32e-05	6.93e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Topiramate—epilepsy syndrome	1.32e-05	6.9e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Topiramate—epilepsy syndrome	1.32e-05	6.9e-05	CcSEcCtD
Hydromorphone—Dizziness—Gabapentin—epilepsy syndrome	1.31e-05	6.86e-05	CcSEcCtD
Hydromorphone—Nausea—Pregabalin—epilepsy syndrome	1.28e-05	6.72e-05	CcSEcCtD
Hydromorphone—Vomiting—Gabapentin—epilepsy syndrome	1.26e-05	6.59e-05	CcSEcCtD
Hydromorphone—Rash—Gabapentin—epilepsy syndrome	1.25e-05	6.54e-05	CcSEcCtD
Hydromorphone—Dermatitis—Gabapentin—epilepsy syndrome	1.25e-05	6.53e-05	CcSEcCtD
Hydromorphone—Headache—Gabapentin—epilepsy syndrome	1.24e-05	6.5e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Topiramate—epilepsy syndrome	1.23e-05	6.43e-05	CcSEcCtD
Hydromorphone—Asthenia—Topiramate—epilepsy syndrome	1.2e-05	6.26e-05	CcSEcCtD
Hydromorphone—Pruritus—Topiramate—epilepsy syndrome	1.18e-05	6.17e-05	CcSEcCtD
Hydromorphone—Nausea—Gabapentin—epilepsy syndrome	1.18e-05	6.16e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Topiramate—epilepsy syndrome	1.14e-05	5.97e-05	CcSEcCtD
Hydromorphone—Dizziness—Topiramate—epilepsy syndrome	1.1e-05	5.77e-05	CcSEcCtD
Hydromorphone—Vomiting—Topiramate—epilepsy syndrome	1.06e-05	5.55e-05	CcSEcCtD
Hydromorphone—Rash—Topiramate—epilepsy syndrome	1.05e-05	5.5e-05	CcSEcCtD
Hydromorphone—Dermatitis—Topiramate—epilepsy syndrome	1.05e-05	5.5e-05	CcSEcCtD
Hydromorphone—Headache—Topiramate—epilepsy syndrome	1.04e-05	5.47e-05	CcSEcCtD
Hydromorphone—Nausea—Topiramate—epilepsy syndrome	9.9e-06	5.18e-05	CcSEcCtD
Hydromorphone—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.53e-06	0.000101	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.51e-06	0.000101	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT3—epilepsy syndrome	6.5e-06	0.000101	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AGT—epilepsy syndrome	6.48e-06	0.000101	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—POMC—epilepsy syndrome	6.45e-06	0.0001	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	6.44e-06	0.0001	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	6.44e-06	0.0001	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NTRK2—epilepsy syndrome	6.4e-06	9.94e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SST—epilepsy syndrome	6.4e-06	9.94e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCR2—epilepsy syndrome	6.4e-06	9.94e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	6.38e-06	9.92e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	6.38e-06	9.92e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ADAM10—epilepsy syndrome	6.34e-06	9.86e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—DUSP6—epilepsy syndrome	6.34e-06	9.85e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CCL2—epilepsy syndrome	6.32e-06	9.81e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	6.3e-06	9.79e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	6.26e-06	9.73e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	6.25e-06	9.71e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	6.24e-06	9.7e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	6.24e-06	9.69e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—BCHE—epilepsy syndrome	6.22e-06	9.66e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HES1—epilepsy syndrome	6.19e-06	9.61e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.17e-06	9.59e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.14e-06	9.54e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ADSL—epilepsy syndrome	6.12e-06	9.51e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.05e-06	9.41e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—FYN—epilepsy syndrome	6.02e-06	9.35e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.02e-06	9.35e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	6.02e-06	9.35e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	6.01e-06	9.33e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GLUL—epilepsy syndrome	6e-06	9.32e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—S100B—epilepsy syndrome	6e-06	9.32e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—H2AFX—epilepsy syndrome	6e-06	9.31e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	5.99e-06	9.3e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MEF2C—epilepsy syndrome	5.98e-06	9.3e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—HMOX1—epilepsy syndrome	5.98e-06	9.3e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	5.96e-06	9.27e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	5.94e-06	9.23e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SOCS3—epilepsy syndrome	5.94e-06	9.23e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	5.93e-06	9.21e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDC42—epilepsy syndrome	5.93e-06	9.21e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	5.9e-06	9.17e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	5.9e-06	9.17e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CAT—epilepsy syndrome	5.9e-06	9.17e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	5.89e-06	9.15e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	5.88e-06	9.14e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PLCB1—epilepsy syndrome	5.87e-06	9.11e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—TH—epilepsy syndrome	5.84e-06	9.08e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.82e-06	9.05e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.82e-06	9.05e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.82e-06	9.05e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.82e-06	9.05e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.82e-06	9.05e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.78e-06	8.99e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	5.76e-06	8.95e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.75e-06	8.94e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ABCB1—epilepsy syndrome	5.74e-06	8.92e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AVP—epilepsy syndrome	5.74e-06	8.91e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NGF—epilepsy syndrome	5.72e-06	8.88e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	5.59e-06	8.69e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCR5—epilepsy syndrome	5.56e-06	8.64e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.56e-06	8.64e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.51e-06	8.56e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	5.49e-06	8.53e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	5.45e-06	8.47e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HTR2A—epilepsy syndrome	5.44e-06	8.46e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HES1—epilepsy syndrome	5.43e-06	8.43e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.4e-06	8.38e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	5.36e-06	8.33e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.35e-06	8.31e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GPX1—epilepsy syndrome	5.34e-06	8.29e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	5.34e-06	8.29e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.33e-06	8.27e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.33e-06	8.27e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.33e-06	8.27e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—FYN—epilepsy syndrome	5.28e-06	8.2e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—H2AFX—epilepsy syndrome	5.26e-06	8.17e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MEF2C—epilepsy syndrome	5.25e-06	8.15e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TSC2—epilepsy syndrome	5.17e-06	8.03e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AGT—epilepsy syndrome	5.17e-06	8.03e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.14e-06	7.98e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.13e-06	7.96e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.07e-06	7.88e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	5.07e-06	7.88e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—APOE—epilepsy syndrome	5.06e-06	7.86e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	5.02e-06	7.8e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NGF—epilepsy syndrome	5.01e-06	7.79e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	5.01e-06	7.78e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	4.96e-06	7.7e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.95e-06	7.69e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.95e-06	7.69e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	4.88e-06	7.58e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	4.88e-06	7.58e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	4.88e-06	7.58e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—HMOX1—epilepsy syndrome	4.88e-06	7.58e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	4.85e-06	7.53e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	4.84e-06	7.52e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	4.84e-06	7.52e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CAT—epilepsy syndrome	4.81e-06	7.48e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	4.77e-06	7.42e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	4.77e-06	7.42e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	4.75e-06	7.39e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ABCB1—epilepsy syndrome	4.68e-06	7.27e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AGT—epilepsy syndrome	4.68e-06	7.27e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.66e-06	7.23e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—APOE—epilepsy syndrome	4.59e-06	7.13e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	4.59e-06	7.12e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	4.54e-06	7.05e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	4.53e-06	7.04e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.53e-06	7.04e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.51e-06	7e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	4.46e-06	6.93e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	4.44e-06	6.9e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	4.44e-06	6.89e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	4.43e-06	6.89e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.41e-06	6.86e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.41e-06	6.86e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.41e-06	6.86e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GPX1—epilepsy syndrome	4.35e-06	6.76e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	4.35e-06	6.75e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	4.35e-06	6.75e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.29e-06	6.66e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	4.25e-06	6.61e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	4.24e-06	6.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.21e-06	6.54e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.21e-06	6.54e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	4.19e-06	6.5e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	4.17e-06	6.48e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	4.12e-06	6.41e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.12e-06	6.4e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.04e-06	6.27e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	4.03e-06	6.27e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.98e-06	6.18e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.96e-06	6.15e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.94e-06	6.13e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—POMC—epilepsy syndrome	3.94e-06	6.12e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.89e-06	6.04e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.88e-06	6.02e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.85e-06	5.99e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	3.84e-06	5.97e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.84e-06	5.97e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	3.83e-06	5.95e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	3.83e-06	5.95e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.82e-06	5.93e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AGT—epilepsy syndrome	3.82e-06	5.93e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	3.81e-06	5.92e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.79e-06	5.89e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	3.75e-06	5.83e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—APOE—epilepsy syndrome	3.74e-06	5.81e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	3.73e-06	5.8e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	3.67e-06	5.71e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.63e-06	5.65e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—epilepsy syndrome	3.59e-06	5.58e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	3.57e-06	5.54e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	3.54e-06	5.5e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.53e-06	5.48e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	3.52e-06	5.47e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	3.5e-06	5.44e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.46e-06	5.37e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.45e-06	5.36e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	3.37e-06	5.24e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.31e-06	5.14e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.3e-06	5.12e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.28e-06	5.1e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.27e-06	5.08e-05	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.25e-06	5.05e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	3.22e-06	5.01e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	3.22e-06	5e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—POMC—epilepsy syndrome	3.21e-06	4.99e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.19e-06	4.96e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.19e-06	4.96e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.15e-06	4.9e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.14e-06	4.89e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	3.14e-06	4.88e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	3.13e-06	4.86e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	3.13e-06	4.86e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.12e-06	4.84e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.11e-06	4.83e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—TH—epilepsy syndrome	3.1e-06	4.81e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.08e-06	4.79e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—TH—epilepsy syndrome	3.07e-06	4.77e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	3.07e-06	4.77e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	3.04e-06	4.73e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.02e-06	4.7e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	2.95e-06	4.58e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—epilepsy syndrome	2.93e-06	4.55e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.85e-06	4.43e-05	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.85e-06	4.43e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	2.82e-06	4.39e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	2.8e-06	4.36e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	2.74e-06	4.26e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	2.73e-06	4.24e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	2.67e-06	4.14e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	2.65e-06	4.11e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.6e-06	4.04e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.59e-06	4.03e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	2.59e-06	4.02e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.59e-06	4.02e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.56e-06	3.98e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—epilepsy syndrome	2.56e-06	3.98e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.55e-06	3.96e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.53e-06	3.94e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.53e-06	3.93e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.52e-06	3.91e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.48e-06	3.86e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.46e-06	3.82e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	2.46e-06	3.82e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.41e-06	3.74e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	2.4e-06	3.72e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.39e-06	3.71e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	2.32e-06	3.6e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.31e-06	3.59e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.29e-06	3.55e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.27e-06	3.53e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.25e-06	3.5e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.19e-06	3.4e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.16e-06	3.36e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.16e-06	3.35e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	2.08e-06	3.23e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.06e-06	3.19e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.03e-06	3.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TH—epilepsy syndrome	2.03e-06	3.15e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.02e-06	3.15e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.02e-06	3.14e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.01e-06	3.12e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.98e-06	3.08e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.97e-06	3.05e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	1.74e-06	2.71e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.7e-06	2.65e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.69e-06	2.63e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.69e-06	2.62e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.67e-06	2.59e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.62e-06	2.52e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AKT1—epilepsy syndrome	1.58e-06	2.45e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.55e-06	2.41e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.54e-06	2.39e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	1.53e-06	2.37e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.51e-06	2.34e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.36e-06	2.11e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.35e-06	2.09e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.32e-06	2.06e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.3e-06	2.01e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.29e-06	2.01e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AKT1—epilepsy syndrome	1.29e-06	2e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.11e-06	1.73e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.02e-06	1.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.88e-07	1.38e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.83e-07	1.06e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AKT1—epilepsy syndrome	6.77e-07	1.05e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.47e-07	6.94e-06	CbGpPWpGaD
